| 000 | 01849 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515011456.0 | ||
| 264 | 0 | _c20060112 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0363-6771 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGroppo, Francisco Carlos | |
| 245 | 0 | 0 |
_aAntimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. _h[electronic resource] |
| 260 |
_bGeneral dentistry _c |
||
| 300 |
_a410-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin _xpharmacology |
| 650 | 0 | 4 |
_aAmoxicillin-Potassium Clavulanate Combination _xpharmacology |
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzithromycin _xpharmacology |
| 650 | 0 | 4 |
_aCefazolin _xpharmacology |
| 650 | 0 | 4 |
_aClarithromycin _xpharmacology |
| 650 | 0 | 4 |
_aClindamycin _xpharmacology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEndocarditis, Bacterial _xphysiopathology |
| 650 | 0 | 4 |
_aErythromycin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPenicillin G _xpharmacology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSaliva _xmicrobiology |
| 650 | 0 | 4 |
_aSkin _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aViridans Streptococci _xdrug effects |
| 700 | 1 | _aCastro, Flavia Meira | |
| 700 | 1 | _aPacheco, Aline Barros | |
| 700 | 1 | _aMotta, Rogerio Heladio | |
| 700 | 1 | _aFilho, Thales Rocha de Mattos | |
| 700 | 1 | _aRamacciato, Juliana Cama | |
| 700 | 1 | _aFlorio, Flavia Martao | |
| 700 | 1 | _aMeechan, John Gerard | |
| 773 | 0 |
_tGeneral dentistry _gvol. 53 _gno. 6 _gp. 410-3 |
|
| 999 |
_c15985701 _d15985701 |
||